RU93046317A - Хиндроитиназа, способ ее получения и содержание ее фармацевтические композиции - Google Patents

Хиндроитиназа, способ ее получения и содержание ее фармацевтические композиции

Info

Publication number
RU93046317A
RU93046317A RU93046317/14A RU93046317A RU93046317A RU 93046317 A RU93046317 A RU 93046317A RU 93046317/14 A RU93046317/14 A RU 93046317/14A RU 93046317 A RU93046317 A RU 93046317A RU 93046317 A RU93046317 A RU 93046317A
Authority
RU
Russia
Prior art keywords
chondroitinase abc
amino acid
terminal amino
chindroitinase
contents
Prior art date
Application number
RU93046317/14A
Other languages
English (en)
Other versions
RU2144833C1 (ru
Inventor
Хосимота Нобуказу
Матизуки Хидео
Хамаи Акио
Исикава Синити
Торикаи Мисако
Мияти Исао
Original Assignee
Сейкагаку Когио Кабусики Кайся (Сейкагаку Корпорейшн)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP31098092A external-priority patent/JP3895782B2/ja
Application filed by Сейкагаку Когио Кабусики Кайся (Сейкагаку Корпорейшн) filed Critical Сейкагаку Когио Кабусики Кайся (Сейкагаку Корпорейшн)
Publication of RU93046317A publication Critical patent/RU93046317A/ru
Application granted granted Critical
Publication of RU2144833C1 publication Critical patent/RU2144833C1/ru

Links

Claims (1)

  1. Кристаллизующаяся очищенная хондроитиназа ABC с молекулярной массой около 100000 получена методом электрофореза с использованием додецилсульфата натрия - полиакриламидного геля (SDS - PAGE) и методом гельпроникающей хроматографии содержит аланин в качестве N -концевой аминокислоты и пролин в качестве C - концевой аминокислоты. Способ очистки кристаллизующейся очищенной хондроитиназы ABC включает удаление нуклеиновой кислоты раствором поверхностно-активного вещества из экстракта, полученного из клеток микроорганизмов, продуцирующих хондроитиназу ABC, и хроматографирование при градиентном концентрированном элюировании с применением слабой катионо-обменной смолы или сильной катионо-обменной смолы. Композиция включает зондроитиназу и сывороточный альбумин, желатин или неионное поверхностно-активное вещество.
RU93046317A 1992-06-26 1993-06-25 Хондроитиназа, способ ее получения и включающие ее фармацевтические композиции RU2144833C1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP192882/1992 1992-06-26
JP19288292 1992-06-26
JP310980/1992 1992-10-26
JP31098092A JP3895782B2 (ja) 1992-10-26 1992-10-26 コンドロイチナーゼ組成物およびそれを含有する注射用製剤

Publications (2)

Publication Number Publication Date
RU93046317A true RU93046317A (ru) 1996-05-20
RU2144833C1 RU2144833C1 (ru) 2000-01-27

Family

ID=26507572

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93046317A RU2144833C1 (ru) 1992-06-26 1993-06-25 Хондроитиназа, способ ее получения и включающие ее фармацевтические композиции

Country Status (10)

Country Link
US (3) US5496718A (ru)
EP (1) EP0576294B1 (ru)
KR (1) KR100280779B1 (ru)
AT (1) ATE192486T1 (ru)
CA (1) CA2099138C (ru)
DE (1) DE69328519T2 (ru)
DK (1) DK0576294T3 (ru)
ES (1) ES2146600T3 (ru)
RU (1) RU2144833C1 (ru)
SG (1) SG50677A1 (ru)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496718A (en) * 1992-06-26 1996-03-05 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Chondroitinase ABC isolated from proteus vulgaris ATCC 6896
JP3419811B2 (ja) * 1993-02-24 2003-06-23 マルハ株式会社 コンドロイチナーゼ遺伝子
US7008783B1 (en) 1992-09-22 2006-03-07 Maruha Corporation Gene encoding chondroitinase ABC and uses therefor
AU697156B2 (en) * 1993-04-23 1998-10-01 American Cyanamid Company Cloning and expression of the chondroitinase I and II genes from (p. vulgaris)
AU1176595A (en) * 1993-11-12 1995-05-29 International Technology Management Associates, Ltd. Methods of repairing connective tissues
JPH10500843A (ja) * 1994-04-22 1998-01-27 アメリカン・サイアナミド・カンパニー コンドロイチナーゼｉおよびｉｉ、その製造法および用途
US5498536A (en) * 1994-04-22 1996-03-12 American Cyanamid Company Chondroitinase II from Proteus vulgaris
US5525500A (en) * 1994-04-22 1996-06-11 American Cyanamid Company Chromatographic process for the copurification of chondroitinase I and II proteins from Proteus vulgaris
US5888798A (en) * 1995-06-07 1999-03-30 American Cyanamid Company Chondroitinase I and chondroitinase II producing mutants of P. vulgaris
EP0747469A1 (en) 1995-06-08 1996-12-11 The Procter & Gamble Company Cleaning compositions comprising chondroitinase
DE69829605T2 (de) * 1997-05-02 2006-02-09 Seikagaku Corp. Chondroitinase enthaltende Zusammensetzungen
JPH1149698A (ja) 1997-07-31 1999-02-23 Santen Pharmaceut Co Ltd 安定性を向上させたラクトフェリンの水性製剤
US6063378A (en) * 1997-08-22 2000-05-16 Seikagaku Corporation Therapeutic agent for herniated intervertebral disc
AU6875900A (en) 1999-09-08 2001-04-10 Chugai Seiyaku Kabushiki Kaisha Protein solution preparation and method of stabilizing the same
US9677829B2 (en) 2001-06-01 2017-06-13 Mitsubishi Paper Mills Limited Total heat exchanging element paper
BR0211888A (pt) 2001-08-13 2004-08-24 Univ Florida Res Foudantion In Materiais e métodos para promoção de reparo de tecido nervoso
GB0205022D0 (en) 2002-03-04 2002-04-17 Univ Cambridge Tech Materials and methods for the treatment of cns damage
US8183350B2 (en) * 2002-05-04 2012-05-22 Acorda Therapeutics, Inc. Compositions and methods for promoting neuronal outgrowth
CA2493509C (en) * 2002-06-03 2010-03-09 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from chondroitinase b
AU2003265561A1 (en) * 2002-08-15 2004-03-03 Acorda Therapeutics, Inc. Chimeric protein
CA2508948A1 (en) * 2002-12-16 2004-07-15 Halozyme, Inc. Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
US20090123367A1 (en) * 2003-03-05 2009-05-14 Delfmems Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases
NZ542873A (en) 2003-03-05 2008-07-31 Halozyme Inc Soluble, neutral-active hyaluronidase activity glycoprotein (sHASEGP) that is produced with high yield in a mammalian expression system by introducing nucleic acids that lack a narrow region encoding amino acids in the carboxy terminus of the human PH20 cDNA
US20060104968A1 (en) * 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
US7871607B2 (en) * 2003-03-05 2011-01-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
US7959914B2 (en) 2003-05-16 2011-06-14 Acorda Therapeutics, Inc. Methods of reducing extravasation of inflammatory cells
EP1631234B1 (en) * 2003-05-16 2011-09-14 Acorda Therapeutics, Inc. Compositions and methods for the treatment of cns injuries
EP3211084B1 (en) * 2003-05-16 2019-03-27 Acorda Therapeutics, Inc. Proteoglycan degrading mutants for treatment of cns
RU2259350C2 (ru) * 2003-07-14 2005-08-27 Открытое акционерное общество "Пигмент" Способ получения анилина и/или n-метиланилина и катализатор для него
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
US7507570B2 (en) * 2004-03-10 2009-03-24 Massachusetts Institute Of Technology Recombinant chondroitinase ABC I and uses thereof
MXPA06013345A (es) * 2004-05-18 2008-10-31 Acorda Therapeutics Inc Metodos para purificar condrointinasa y sus formulaciones estables.
WO2005122734A2 (en) * 2004-06-14 2005-12-29 The Research Foundation Of State University Of New York Nanosphere/microsphere delivery system for the treatment of spinal cord injury
JP2008514240A (ja) * 2004-10-01 2008-05-08 インヴィトロジェン コーポレーション 生体分子のインビトロ合成用の供給バッファー、系、及び方法
RU2275190C1 (ru) * 2005-04-06 2006-04-27 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Средство для лечения болезней суставов
JP5189985B2 (ja) 2005-09-26 2013-04-24 アコーダ セラピューティクス、インク． コンドロイチナーゼａｂｃｉ変異体を用いた組成物およびその使用方法
WO2007063691A1 (ja) 2005-11-29 2007-06-07 Sanyo Chemical Industries, Ltd. 溶菌剤
CA3009034C (en) 2006-10-10 2020-08-18 Acorda Therapeutics, Inc. Compositions and methods of using chondroitinase abci mutants
US20110059508A1 (en) 2007-06-29 2011-03-10 National University Corporation Nagoya University Improving agent for dysfunction due to neuropathy and rho kinase activation inhibitor
US20090286289A1 (en) * 2008-03-10 2009-11-19 Pang Danny Z Production of Hyaluronate Unsaturated Disaccharides and its Application
WO2012081227A1 (ja) 2010-12-13 2012-06-21 生化学工業株式会社 椎間板ヘルニア治療剤
ES2916834T3 (es) 2014-09-27 2022-07-06 Sumitomo Pharma Co Ltd Composición farmacéutica para inyección
US9796970B1 (en) 2017-04-24 2017-10-24 Advantek Serum Laboratories Ltd. Production of high purity chondroitinase ABC
EP3760220B1 (en) 2018-02-28 2025-02-19 Seikagaku Corporation A package comprising lyophilized chondroitinase abc and method for manufacturing the same
JP7321142B2 (ja) 2018-02-28 2023-08-04 生化学工業株式会社 医薬組成物、包装体及びその製造方法
JP2023532544A (ja) * 2020-07-01 2023-07-28 メディミューン，エルエルシー 生物学的製剤を精製するための洗浄剤及び方法
CN114409731B (zh) * 2022-01-05 2023-08-11 浙江省农业科学院 同时具有激活乙醇脱氢酶和乙醛脱氢酶活性的两种多肽

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549500A (en) * 1967-07-22 1970-12-22 Seikagaku Kogyo Co Ltd Novel chondroitinase and method of its recovery
JPS4832351B1 (ru) * 1968-06-12 1973-10-05
JPS4713704Y1 (ru) * 1971-09-29 1972-05-18
JPS6031479B2 (ja) * 1978-02-10 1985-07-22 生化学工業株式会社 純コンドロイチナ−ゼｃの製造法
JPS6031478B2 (ja) * 1978-02-10 1985-07-22 生化学工業株式会社 純コンドロイチナ−ゼｂの製造法
DK151634C (da) * 1978-09-29 1988-06-20 Mitsubishi Chem Ind Fremgangsmaade til rensning af langkaedet acyl-coenzym-a-syntetase
US4623625A (en) * 1983-04-21 1986-11-18 La Trobe University Enzyme extraction and purification processes
US4696816A (en) * 1985-11-07 1987-09-29 Brown Mark D Method for treating intervertebral disc displacement with enzymes
JPS62122588A (ja) * 1985-11-22 1987-06-03 Taiyo Fishery Co Ltd 純コンドロイチナ−ゼの製造法
JP2726275B2 (ja) * 1988-08-24 1998-03-11 生化学工業株式会社 グリコサミノグリカン分解酵素の精製法
JP2919496B2 (ja) * 1989-08-24 1999-07-12 生化学工業株式会社 新規コンドロイチン硫酸分解酵素、それらを産生する微生物並びにそれらの製法
JP3140797B2 (ja) * 1991-04-26 2001-03-05 生化学工業株式会社 安定化コンドロイチナーゼａｂｃ、その保存方法及び治療剤
US5496718A (en) * 1992-06-26 1996-03-05 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Chondroitinase ABC isolated from proteus vulgaris ATCC 6896

Similar Documents

Publication Publication Date Title
RU93046317A (ru) Хиндроитиназа, способ ее получения и содержание ее фармацевтические композиции
CA2099138A1 (en) Chondroitinase, Process for Preparing the Same, and Pharmaceutical Composition Comprising the Same
Dimuzio et al. Phosphophoryns—major noncollagenous proteins of rat incisor dentin
Yonemasu et al. Chemical studies on Clq; a modulator of immunoglobulin biology
Calvete et al. A procedure for the large-scale isolation of major bovine seminal plasma proteins
Lozier et al. Complete amino acid sequence of human plasma beta 2-glycoprotein I.
Morris et al. Characterization of monellin, a protein that tastes sweet
DK0784632T3 (da) Fremgangsmåde til udvinding af højren von Willebrand-faktor
Joubert Snake venom toxins: The amino acid sequences of two toxins from Ophiophagus hannah (King Cobra) venom
Bailey et al. Partial characterization of a second basement membrane collagen in human placenta: evidence for the existence of two type IV collagen molecules
US4672108A (en) Crystalline human leukocyte interferon
CA2265935A1 (en) Heat shock protein complexes
DK0754231T3 (da) Peptidfragment fra G-proteinet fra respiratorisk syncytialvirus, immunogent middel, farmaceutisk præparat, der indeholder det, og fremgangsmåde til fremstilling deraf
NZ509135A (en) A third generation intravenous immunoglobulin G (IVIG) purified using column chromatographic ion exchange methods
Bornstein Comparative sequence studies of rat skin and tendon collagen. II. Absence of a short sequence at the amino terminus of the skin α1 chain
CA2058676C (en) Process for isolating human albumin from supernatant iv, in particular iv-4, or from cohn's fraction v or from an analogous supernatant or fraction
Rathnam et al. Subunits of luteinizing hormone from human pituitary glands
JPS63503352A (ja) タンパク質の精製
KR860004149A (ko) 재조합 dna 기술에 의해 제조된 생리적 활성 물질의 정제방법
Lopez et al. The complete amino acid sequence of human complex-forming glycoprotein heterogeneous in charge (protein HC)
PH24961A (en) Monocional antibodies for human non-small cell lung carcinomas
DK0419878T3 (da) Nye aprotinin-varianter og genteknologisk fremgangsmåde til mikrobiel fremstilling af disse varianter i homogent processeret form
US4617378A (en) Purification of biologically active human immune interferon
Sugiyama et al. Isolation and characterization of histamine-releasing peptides from human parotid saliva
Swart et al. Studies on the high-sulphur proteins of reduced Merino wool. Amino acid sequence of protein SCMKB-IIIB4